News and stories

Brandon Capital has the funds, experience and expertise to support life science companies from proof-of-concept through to commercialisation.

Avasa’s arterial coupler makes microvascular surgery quicker and safer empowering surgeons to securely and efficiently link microvascular arteries in under 10 minutes.

Scentian Bio's biosensor technology, based on insect olfactory receptors combined with AI, has created a detection that is 1000x more sensitive than that of even the best beagle.

An Auckland startup that has developed dairy-identical proteins has teamed up with world-renowned ice-cream maker Gianpaolo Grazioli​ to put its innovation to the taste test.

The world of implantable medical devices is a fascinating and evolving market that has traditionally been full of passive devices (such as hip joints) and active stimulatory devices (such as pacemakers). Kitea Health, recipients of the Ārohia Innovation Trailblazer Grant, are leading the advancement of this area with their implantable pressure sensor devices that allow proactive management of chronic disease. The micro devices provide real time, accurate monitoring information to clinicians, so they can provide treatment early.

At a glance Before gaining one of the first commercial licences in New Zealand to grow and supply cannabis-derived medicines, Rua Bioscience spent years investing in R&D projects and developing their facilities.

At a glance Biotech startup Amaroq Therapeutics is developing therapies to fight some of the most hard-to-treat and prevalent cancers.

The Paeroa-based company – which provides innovative, proven and effective seaweed products that benefit people and the planet – was named Callaghan Innovation Hi-Tech Māori Kamupene o te Tau/Māori Company of the Year at the 2022 NZ Hi-Tech Awards.

At a glance Helico is aiming to produce therapeutic compounds from plants and, ultimately, ‘edible medicine’, with the technology potentially increasing accessibility and affordability of essential medicines.

At a glance Biotelliga is developing biologically based technologies - that work consistently - to help growers protect their crops from pests and disease, reducing the reliance on synthetic chemicals.

Scentian Bio founder Andrew Králíček would know.

At a glance Wellington-based Wilderlab is making environmental DNA (eDNA) testing more accessible, helping monitor and understand our freshwater ecosystems a lot more.